W. Van den Bogaert

3.2k total citations · 1 hit paper
69 papers, 2.4k citations indexed

About

W. Van den Bogaert is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiation. According to data from OpenAlex, W. Van den Bogaert has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 25 papers in Cancer Research and 19 papers in Radiation. Recurrent topics in W. Van den Bogaert's work include Breast Cancer Treatment Studies (24 papers), Advanced Radiotherapy Techniques (19 papers) and Head and Neck Cancer Studies (15 papers). W. Van den Bogaert is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Advanced Radiotherapy Techniques (19 papers) and Head and Neck Cancer Studies (15 papers). W. Van den Bogaert collaborates with scholars based in Belgium, Netherlands and France. W. Van den Bogaert's co-authors include M. van Glabbeke, Jean-Claude Horiot, Howard D. Thames, Søren M. Bentzen, Ingela Turesson, Marie Overgaard, R. Le Fur, S Schraub, Emmanuel van der Schueren and M. Bolla and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

W. Van den Bogaert

69 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1992 496 citations Jean-Claude Horiot, R. Le Fur et al. Radiotherapy and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Van den Bogaert Belgium	23	936	848	722	686	643	69	2.4k
Renzo Corvò Italy	27	1.1k 1.1×	1.1k 1.3×	931 1.3×	978 1.4×	432 0.7×	179	2.8k
Martin Housset France	20	844 0.9×	255 0.3×	561 0.8×	374 0.5×	594 0.9×	37	1.9k
Cordula Petersen Germany	32	981 1.0×	395 0.5×	1.0k 1.4×	624 0.9×	444 0.7×	116	2.7k
Kwan Ho Cho South Korea	29	1.3k 1.4×	302 0.4×	637 0.9×	538 0.8×	970 1.5×	104	2.6k
James P. Morden United Kingdom	17	1.1k 1.2×	1.1k 1.3×	848 1.2×	627 0.9×	494 0.8×	51	2.6k
E. Touboul France	33	1.7k 1.8×	275 0.3×	1.3k 1.8×	1.4k 2.0×	928 1.4×	144	4.2k
William J. Spanos United States	29	810 0.9×	1.0k 1.2×	993 1.4×	1.0k 1.5×	332 0.5×	60	2.8k
Teruki Teshima Japan	27	1.6k 1.7×	370 0.4×	582 0.8×	744 1.1×	1.1k 1.7×	200	2.9k
F. Adab United Kingdom	10	939 1.0×	997 1.2×	906 1.3×	849 1.2×	461 0.7×	14	2.2k
Rafael Martínez‐Monge Spain	27	984 1.1×	281 0.3×	926 1.3×	919 1.3×	578 0.9×	128	2.3k

Countries citing papers authored by W. Van den Bogaert

Since Specialization

Citations

This map shows the geographic impact of W. Van den Bogaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Van den Bogaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Van den Bogaert more than expected).

Fields of papers citing papers by W. Van den Bogaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Van den Bogaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Van den Bogaert. The network helps show where W. Van den Bogaert may publish in the future.

Co-authorship network of co-authors of W. Van den Bogaert

This figure shows the co-authorship network connecting the top 25 collaborators of W. Van den Bogaert. A scholar is included among the top collaborators of W. Van den Bogaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Van den Bogaert. W. Van den Bogaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schepper, Maxim De, Tatjana Geukens, Karen Van Baelen, et al.. (2023). 2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC). ESMO Open. 8(1). 101226–101226. 1 indexed citations

Bogaert, W. Van den, et al.. (2023). Suicidal sodium nitrite intoxication: a case report focusing on the postmortem findings and toxicological analyses—review of the literature. Forensic Science Medicine and Pathology. 20(3). 949–964. 5 indexed citations

Horiot, J.C., W. Van den Bogaert, K. Kian Ang, et al.. (2015). European Organization for Research on Treatment of Cancer Trials Using Radiotherapy with Multiple Fractions per Day. Frontiers of radiation therapy and oncology. 22. 149–161. 3 indexed citations

Wagemans, Johan, Benoit Beuselinck, Sandra Nuyts, et al.. (2010). A CASE SERIES OF EMBRYONAL RHABDOMYOSARCOMA OF THE HEAD AND NECK IN ADULTS. Acta Clinica Belgica. 65(6). 404–410. 11 indexed citations

Jones, Helen, Ninja Antonini, Alain Fourquet, et al.. (2007). The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial. International Journal of Radiation Oncology*Biology*Physics. 69(3). S2–S3. 6 indexed citations

Neven, Patrick, Ben Van Calster, Sabine Van Huffel, et al.. (2007). Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Research and Treatment. 110(1). 153–159. 12 indexed citations

Bartelink, H., P Poortmans, Jacques Borger, et al.. (2002). Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(9). 416–423. 1 indexed citations

Lievens, Yolande, et al.. (2001). Influence of systemic therapy on pulmonary function tests in breast cancer patients irradiated to the internal mammary and medial supraclavicular lymph node chain. European Journal of Cancer. 37. S184–S184. 1 indexed citations

Aerts, Joeri L., Wim Wynendaele, Robert Paridaens, et al.. (2001). A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood. Annals of Oncology. 12(1). 39–46. 73 indexed citations

10.

Hermans, Robert, Eric Fossion, Charis Ioannides, et al.. (1996). CT findings in osteoradionecrosis of the mandible. Skeletal Radiology. 25(1). 31–36. 46 indexed citations

11.

Bontemps, P., R. Le Fur, W. Van den Bogaert, et al.. (1996). Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique. 83(4). 314–320. 9 indexed citations

12.

Bogaert, W. Van den, M. van Glabbeke, M. Piérart, et al.. (1994). Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy. European Journal of Cancer. 30(14). 2073–2081. 22 indexed citations

13.

Horiot, Jean-Claude, A.C. Begg, R. Le Fur, et al.. (1994). Present Status of EORTC Trials of Hyperfractionated and Accelerated Radiotherapy on Head and Neck Carcinoma. Recent results in cancer research. 134. 111–119. 11 indexed citations

14.

Schaake-Koning, C., W. Van den Bogaert, Otilia Dalesio, et al.. (1993). Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer. 9(1-6). 245–248. 2 indexed citations

15.

Leunens, G., Jan Verstraete, W. Van den Bogaert, et al.. (1992). Human errors in data transfer during the preparation and delivery of radiation treatment affecting the final result: “garbage in, garbage out”. Radiotherapy and Oncology. 23(4). 217–222. 75 indexed citations

16.

Bogaert, W. Van den. (1991). The relation between radiotherapist, surgeon, pathologist and physicist in the treatment of early breast cancer. Radiotherapy and Oncology. 22(4). 219–221. 3 indexed citations

17.

Horiot, Jean-Claude, R. Le Fur, T. Nguyen, et al.. (1990). Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. European Journal of Cancer and Clinical Oncology. 26(7). 779–780. 48 indexed citations

18.

Schueren, Emmanuel van der, W. Van den Bogaert, L. Vanuytsel, & E. Van Limbergen. (1990). Radiotherapy by multiple fractions per day (mfd) in head and neck cancer: Acute reactions of skin and mucosa. International Journal of Radiation Oncology*Biology*Physics. 19(2). 301–311. 63 indexed citations

19.

Thames, Howard D., Søren M. Bentzen, Ingela Turesson, Marie Overgaard, & W. Van den Bogaert. (1990). Time-dose factors in radiotherapy: a review of the human data. Radiotherapy and Oncology. 19(3). 219–235. 321 indexed citations

20.

Thames, Howard D., Søren M. Bentzen, Ingela Turesson, Marie Overgaard, & W. Van den Bogaert. (1989). Fractionation Parameters for Human Tissues and Tumors. International Journal of Radiation Biology. 56(5). 701–710. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact